Human Reproduction Update Advance Access originally published online on August 4, 2006
Human Reproduction Update 2006 12(6):685-718; doi:10.1093/humupd/dml034
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A systematic review of tests predicting ovarian reserve and IVF outcome
1 Department of Reproductive Medicine, University Medical Centre Utrecht, Utrecht, 2 Division of Reproductive Endocrinology and Fertility and the IVF Centre, Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre and 3 Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Centre, Amsterdam, The Netherlands
4 To whom correspondence should be addressed at: Department of Reproductive Medicine, Vrije Universiteit Medical Center (VUmc), PO Box 70057, 1007 MB, Amsterdam, The Netherlands. E-mail: cb.lambalk{at}vumc.nl
The age-related decline of the success in IVF is largely attributable to a progressive decline of ovarian oocyte quality and quantity. Over the past two decades, a number of so-called ovarian reserve tests (ORTs) have been designed to determine oocyte reserve and quality and have been evaluated for their ability to predict the outcome of IVF in terms of oocyte yield and occurrence of pregnancy. Many of these tests have become part of the routine diagnostic procedure for infertility patients who undergo assisted reproductive techniques. The unifying goals are traditionally to find out how a patient will respond to stimulation and what are their chances of pregnancy. Evidence-based medicine has progressively developed as the standard approach for many diagnostic procedures and treatment options in the field of reproductive medicine. We here provide the first comprehensive systematic literature review, including an a priori protocolized information retrieval on all currently available and applied tests, namely early-follicular-phase blood values of FSH, estradiol, inhibin B and anti-Müllerian hormone (AMH), the antral follicle count (AFC), the ovarian volume (OVVOL) and the ovarian blood flow, and furthermore the Clomiphene Citrate Challenge Test (CCCT), the exogenous FSH ORT (EFORT) and the gonadotrophin agonist stimulation test (GAST), all as measures to predict ovarian response and chance of pregnancy. We provide, where possible, an integrated receiver operating characteristic (ROC) analysis and curve of all individual evaluated published papers of each test, as well as a formal judgement upon the clinical value. Our analysis shows that the ORTs known to date have only modest-to-poor predictive properties and are therefore far from suitable for relevant clinical use. Accuracy of testing for the occurrence of poor ovarian response to hyperstimulation appears to be modest. Whether the a priori identification of actual poor responders in the first IVF cycle has any prognostic value for their chances of conception in the course of a series of IVF cycles remains to be established. The accuracy of predicting the occurrence of pregnancy is very limited. If a high threshold is used, to prevent couples from wrongly being refused IVF, a very small minority of IVF-indicated cases (
3%) are identified as having unfavourable prospects in an IVF treatment cycle. Although mostly inexpensive and not very demanding, the use of any ORT for outcome prediction cannot be supported. As poor ovarian response will provide some information on OR status, especially if the stimulation is maximal, entering the first cycle of IVF without any prior testing seems to be the preferable strategy.
Key words: IVF/ICSI outcome / ovarian reserve / ovarian stimulation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-N. Hugues, L. Theron-Gerard, C. Coussieu, M. Pasquier, D. Dewailly, and I. Cedrin-Durnerin Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels Hum. Reprod., November 6, 2009; (2009) dep378v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Demeestere, P. Simon, S. Emiliani, A. Delbaere, and Y. Englert Orthotopic and heterotopic ovarian tissue transplantation Hum. Reprod. Update, November 1, 2009; 15(6): 649 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Brodin, T. Bergh, L. Berglund, N. Hadziosmanovic, and J. Holte High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction Hum. Reprod., November 1, 2009; 24(11): 2755 - 2759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kyrou, B. Popovic-Todorovic, H.M. Fatemi, C. Bourgain, P. Haentjens, L. Van Landuyt, and P. Devroey Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum. Reprod., November 1, 2009; 24(11): 2902 - 2909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Wise, K. J. Rothman, E. M. Mikkelsen, H. T. Sorensen, A. Riis, and E. E. Hatch An internet-based prospective study of body size and time-to-pregnancy Hum. Reprod., October 14, 2009; (2009) dep360v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A. C. Artenisio, G. Stabile, and A. Volpe Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum. Reprod. Update, September 30, 2009; (2009) dmp036v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Deb, M. Batcha, B.K. Campbell, K. Jayaprakasan, J.S. Clewes, J.F. Hopkisson, C. Sjoblom, and N.J. Raine-Fenning The predictive value of the automated quantification of the number and size of small antral follicles in women undergoing ART Hum. Reprod., September 1, 2009; 24(9): 2124 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, N.S. Macklon, and on behalf of the ESHRE Special Interest Group for Anti-Mullerian hormone (AMH): what do we still need to know? Hum. Reprod., September 1, 2009; 24(9): 2264 - 2275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Broekmans, M. R. Soules, and B. C. Fauser Ovarian Aging: Mechanisms and Clinical Consequences Endocr. Rev., August 1, 2009; 30(5): 465 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Devroey, B.C.J.M. Fauser, K. Diedrich, and on behalf of the Evian Annual Reproduction (EVAR) Approaches to improve the diagnosis and management of infertility Hum. Reprod. Update, July 1, 2009; 15(4): 391 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander Breast cancer in young women and its impact on reproductive function Hum. Reprod. Update, May 1, 2009; 15(3): 323 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Nelson, R. W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, P. Mitchell, P. Ambrose, and R. Fleming Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum. Reprod., April 1, 2009; 24(4): 867 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Garcia-Velasco and E. Somigliana Management of endometriomas in women requiring IVF: to touch or not to touch Hum. Reprod., March 1, 2009; 24(3): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Haadsma, H. Groen, V. Fidler, L.H.M. Seinen, F.J.M. Broekmans, M.J. Heineman, and A. Hoek The predictive value of ovarian reserve tests for miscarriage in a population of subfertile ovulatory women Hum. Reprod., March 1, 2009; 24(3): 546 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rosendahl, C. Y. Andersen, E. Ernst, L. G. Westergaard, P. E. Rasmussen, A. Loft, and A. N. Andersen Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study Hum. Reprod., November 1, 2008; 23(11): 2475 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Haadsma, H. Groen, V. Fidler, A. Bukman, E.M.A. Roeloffzen, E.R. Groenewoud, F.J.M. Broekmans, M.J. Heineman, and A. Hoek The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women Hum. Reprod., August 1, 2008; 23(8): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yakin and B. Urman What next for preimplantation genetic screening? A clinician's perspective Hum. Reprod., August 1, 2008; 23(8): 1686 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jayaprakasan, J.F. Hopkisson, B.K. Campbell, J. Clewes, I.R. Johnson, and N.J. Raine-Fenning Quantification of the effect of pituitary down-regulation on 3D ultrasound predictors of ovarian response Hum. Reprod., July 1, 2008; 23(7): 1538 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van Disseldorp, M. J. Faddy, A. P. N. Themmen, F. H. de Jong, P. H. M. Peeters, Y. T. van der Schouw, and F. J. M. Broekmans Relationship of Serum Antimullerian Hormone Concentration to Age at Menopause J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2129 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt Relevance of anti-Mullerian hormone measurement in a routine IVF program Hum. Reprod., June 1, 2008; 23(6): 1359 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.J. Vercammen, A. Verloes, H. Van de Velde, and P. Haentjens Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis Hum. Reprod. Update, May 1, 2008; 14(3): 209 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gremlich, S. Fratta, E. Rebellato, R. Uras, D. Reymondin, F. Damnon, M. Germond, and S. Gerber Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism is a predictive factor of clinical pregnancy after IVF Hum. Reprod., May 1, 2008; 23(5): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Scott and R. A. Reijo Pera The road to pluripotence: the research response to the embryonic stem cell debate Hum. Mol. Genet., April 15, 2008; 17(R1): R3 - R9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abir, A. Ben-Haroush, C. Felz, E. Okon, H. Raanani, R. Orvieto, S. Nitke, and B. Fisch Selection of patients before and after anticancer treatment for ovarian cryopreservation Hum. Reprod., April 1, 2008; 23(4): 869 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.E.M. Verhagen, D.J. Hendriks, L.F.J.M.M. Bancsi, B.W.J. Mol, and F.J.M. Broekmans The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis Hum. Reprod. Update, March 1, 2008; 14(2): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.C.J.M. Fauser, K. Diedrich, P. Devroey, and on behalf of the Evian Annual Reproduction (EVAR) Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation Hum. Reprod. Update, January 1, 2008; 14(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H Balen and A. J Rutherford Management of infertility BMJ, September 22, 2007; 335(7620): 608 - 611. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Nelson, R. W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy Hum. Reprod., September 1, 2007; 22(9): 2414 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Siristatidis and S. Bhattacharya Unexplained infertility: does it really exist? Does it matter? Hum. Reprod., August 1, 2007; 22(8): 2084 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jayaprakasan, N. Hilwah, N.R. Kendall, J.F. Hopkisson, B.K. Campbell, I.R. Johnson, and N.J. Raine-Fenning Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum. Reprod., July 1, 2007; 22(7): 1932 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. van der Steeg, P. Steures, M. J. C. Eijkemans, J. D. F. Habbema, P. G. A. Hompes, F. J. Broekmans, P. X. J. M. Bouckaert, P. M. M. Bossuyt, F. van der Veen, B. W. J. Mol, et al. Predictive Value and Clinical Impact of Basal Follicle-Stimulating Hormone in Subfertile, Ovulatory Women J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2163 - 2168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Stillman A 47-Year-Old Woman With Fertility Problems Who Desires a Multiple Pregnancy JAMA, February 28, 2007; 297(8): 858 - 867. [Abstract] [Full Text] [PDF]
|
|